Literature DB >> 21904780

Can sugammadex encapsulation eliminate the antigenic activity of aminosteroidal neuromuscular blocking agent?

Takashi Kawano, Masataka Yokoyama.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21904780     DOI： 10.1007/s00540-011-1223-3

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  5 in total

Review 1.  Anaphylaxis and anesthesia: controversies and new insights.

Authors:  Pascale Dewachter; Claudie Mouton-Faivre; Charles W Emala
Journal:  Anesthesiology       Date:  2009-11       Impact factor: 7.892

2.  Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown.

Authors:  P M Jones; T P Turkstra
Journal:  Anaesthesia       Date:  2010-01       Impact factor: 6.955

3.  Rocuronium-induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment.

Authors:  J Leysen; C H Bridts; L S De Clerck; D G Ebo
Journal:  Anaesthesia       Date:  2011-06       Impact factor: 6.955

4.  Sugammadex in the management of rocuronium-induced anaphylaxis.

Authors:  N J McDonnell; T J G Pavy; L K Green; P R Platt
Journal:  Br J Anaesth       Date:  2010-12-10       Impact factor: 9.166

5.  Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000.

Authors:  Paul Michel Mertes; Marie-Claire Laxenaire; François Alla
Journal:  Anesthesiology       Date:  2003-09       Impact factor: 7.892
  5 in total
  5 in total

1.  Suspicion of duplicate publication regarding "J Anesth 2011; 25:953-4".

Authors:  Kazuyoshi Hirota
Journal:  J Anesth       Date:  2012-04       Impact factor: 2.078

2.  Two Cases of Rocuronium-Induced Anaphylaxis/Anaphylactic Shock Successfully Treated With Sugammadex.

Authors:  Mayumi Hashimoto; Aiji Sato Boku; Naoko Tachi; Yoko Okumura; Kanenori Kadoi; Jun Harada; Masahiro Okuda
Journal:  Anesth Prog       Date:  2019

3.  The effect of rocuronium, sugammadex, and their combination on cardiac muscle and diaphragmatic skeletal muscle cells.

Authors:  Yildiray Kalkan; Habib Bostan; Levent Tumkaya; Yakup Tomak; Mehmet Bostan; Adnan Yilmaz; Hasan Turut; Ahmet Temiz; Alper Yalçin; Alparslan Turan
Journal:  J Anesth       Date:  2012-07-14       Impact factor: 2.078

Review 4.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25

Review 5.  Sugammadex and rocuronium-induced anaphylaxis.

Authors:  Tomonori Takazawa; Hiromasa Mitsuhata; Paul Michel Mertes
Journal:  J Anesth       Date:  2015-12-08       Impact factor: 2.078
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.